Rates of, and factors associated with, switching among generic levothyroxine preparations in commercially insured American adults

被引：0
|
作者：
Juan P. Brito
Yihong Deng
Joseph S. Ross
Nam Hee Choi
David J. Graham
Yandong Qiang
Elena Rantou
Zhong Wang
Liang Zhao
Nilay D. Shah
Kasia J. Lipska
机构：
[1] Mayo Clinic,Division of Endocrinology, Diabetes, Metabolism, Nutrition, Department of Internal Medicine
[2] Mayo Clinic,Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery
[3] Yale School of Medicine,Section of General Internal Medicine and the National Clinician Scholars Program
[4] Yale School of Public Health,Department of Health Policy and Management
[5] Yale-New Haven Hospital,Center for Outcomes Research and Evaluation
[6] U.S. Food and Drug Administration,Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research
[7] U.S. Food and Drug Administration,Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research
[8] U.S. Food and Drug Administration,Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research
[9] Delta Airlines,Section of Endocrinology, Department of Internal Medicine
[10] Yale School of Medicine,undefined
来源：
Endocrine | 2022年 / 76卷
关键词：
Generic; Levothyroxine; Hypothyroidism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：349 / 358
页数：9
相关论文
共 50 条
  • [31] Out-of-pocket Spending on Orphan Drug Prescriptions Among Commercially Insured Adults in 2014
    Kao-Ping Chua
    Rena M. Conti
    Journal of General Internal Medicine, 2019, 34 : 338 - 340
  • [32] Patterns of use of sildenafil among commercially insured adults in the United States: 1998-2002
    Delate, T
    Simmons, VA
    Motheral, BR
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2004, 16 (04) : 313 - 318
  • [33] Characteristics and Outcomes Among US Commercially Insured Transgender Adults With Cirrhosis: A National Cohort Study
    Elhence, Hirsh
    Dodge, Jennifer L.
    Kahn, Jeffrey A.
    Lee, Brian P.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (12): : 2455 - 2461
  • [34] Treatment Of Opioid Use Disorder Among Commercially Insured US Adults, 2008-17
    Shen, Karen
    Barrette, Eric
    Dafny, Leemore S.
    HEALTH AFFAIRS, 2020, 39 (06) : 993 - 1001
  • [35] Healthcare resource utilization and costs associated with postpartum depression among commercially insured households
    Epperson, C. Neill
    Huang, Ming-Yi
    Cook, Keziah
    Gupta, Deepshekhar
    Chawla, Anita
    Greenberg, Paul E.
    Eldar-Lissai, Adi
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (10) : 1707 - 1716
  • [36] Benzodiazepine Use among Medicare,Commercially Insured, and Veteran Older Adults, 2013-2017
    Maust, Donovan T.
    Kim, H. Myra
    Wiechers, Ilse R.
    Ignacio, Rosalinda V.
    Bohnert, Amy S. B.
    Blow, Frederic C.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2021, 69 (01) : 98 - 105
  • [37] Out-of-pocket Spending on Orphan Drug Prescriptions Among Commercially Insured Adults in 2014
    Chua, Kao-Ping
    Conti, Rena M.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2019, 34 (03) : 338 - 340
  • [38] Prevalence of Immunosuppressive Drug Use Among Commercially Insured US Adults, 2018-2019
    Wallace, Beth I.
    Kenney, Brooke
    Malani, Preeti N.
    Clauw, Daniel J.
    Nallamothu, Brahmajee K.
    Waljee, Akbar K.
    JAMA NETWORK OPEN, 2021, 4 (05)
  • [39] Treatment patterns and key factors associated with high treatment costs among commercially insured patients with advanced basal cell carcinoma
    Migden, Michael
    Wei, Jin
    Tang, Wenxi
    Herrera, Vivian
    Xie, Jipan
    Palmer, Jacqueline
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB206 - AB206
  • [40] Prevalence of Pre-Existing Risk Factors for Adverse Events Associated with Atypical Antipsychotics Among Commercially Insured and Medicaid Insured Patients Newly Initiating Atypical Antipsychotics
    Citrome, Leslie
    Johnston, Stephen
    Nadkarni, Anagha
    Sheehan, John J.
    Kamat, Siddhesh A.
    Kalsekar, Iftekhar
    CURRENT DRUG SAFETY, 2014, 9 (03) : 227 - 235
12345